» Articles » PMID: 37239740

The Impact of Telemedicine on Patients with Hidradenitis Suppurativa in the COVID-19 Era

Overview
Specialty Health Services
Date 2023 May 27
PMID 37239740
Authors
Affiliations
Soon will be listed here.
Abstract

(1) Background: Hidradenitis suppurativa is a chronic, inflammatory skin disease. It is characterized by the transformation of normal skin into skin with abscesses, nodules, tunnels, and scars. The most commonly affected areas are the armpits, groins, buttocks, and subscapular area. Patients with HS require constant care under the supervision of the outpatient clinic. Due to the COVID-19 pandemic, consultations have been introduced in the form of telemedicine. The aim of this study was to evaluate the availability of HS treatment during the COVID-19 pandemic and to assess patient satisfaction, problems with access to medical care, and the impact of the pandemic on the course of the disease. (2) Methods: An internet survey with an anonymous questionnaire was used to assess the effectiveness of telemedicine consultations. The survey consisted of 25 closed questions, and responses were kept fully anonymous. (3) Results: Most respondents reported minor problems with accessing specialized HS medical care during the COVID-19 pandemic (n = 25, 35.71%). However, 35.71% (n = 25) of them reported major problems with appointments for specialized ambulatory treatment during the last few months of the pandemic, mainly due to delayed appointments. Almost half of the respondents had been diagnosed with COVID-19 (n = 34, 48.57%), and 58.57% (n = 41) of respondents did not see a correlation between COVID-19 infection and HS progression. (4) Conclusions: Our study showed that the pandemic significantly limited access to medical advice, and patients with hidradenitis suppurativa prefer standard consultations.

Citing Articles

Characteristics and Effectiveness of Mobile- and Web-Based Tele-Emergency Consultation System between Rural and Urban Hospitals in South Korea: A National-Wide Observation Study.

Choi W, Lim Y, Heo T, Lee S, Kim W, Kim S J Clin Med. 2023; 12(19).

PMID: 37834896 PMC: 10573876. DOI: 10.3390/jcm12196252.


The Attitude of Egyptian Patients with Autoimmune and Rheumatic Diseases towards Telemedicine.

Tharwat S, Gamal D Medicina (Kaunas). 2023; 59(9).

PMID: 37763714 PMC: 10533084. DOI: 10.3390/medicina59091595.

References
1.
Bhaskar S, Bradley S, Israeli-Korn S, Menon B, Chattu V, Thomas P . Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium. Front Neurol. 2020; 11:664. PMC: 7339863. DOI: 10.3389/fneur.2020.00664. View

2.
Kruse C, Karem P, Shifflett K, Vegi L, Ravi K, Brooks M . Evaluating barriers to adopting telemedicine worldwide: A systematic review. J Telemed Telecare. 2018; 24(1):4-12. PMC: 5768250. DOI: 10.1177/1357633X16674087. View

3.
Bhaskar S, Bradley S, Chattu V, Adisesh A, Nurtazina A, Kyrykbayeva S . Telemedicine as the New Outpatient Clinic Gone Digital: Position Paper From the Pandemic Health System REsilience PROGRAM (REPROGRAM) International Consortium (Part 2). Front Public Health. 2020; 8:410. PMC: 7505101. DOI: 10.3389/fpubh.2020.00410. View

4.
Zelickson B, Homan L . Teledermatology in the nursing home. Arch Dermatol. 1997; 133(2):171-4. View

5.
Giamarellos-Bourboulis E, Bettoli V, Jemec G, Del Marmol V, Marzano A, Prens E . Anti-COVID-19 measurements for hidradenitis suppurativa patients. Exp Dermatol. 2021; 30 Suppl 1:18-22. PMC: 8207032. DOI: 10.1111/exd.14339. View